GlassScriptPhysician profile
Helen Kaulbach
NPI 1497751374
$43,454.87
in general payments reported to CMS, 2019-2025
37 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $4,063 · 2021: $395 · 2022: $2,861 · 2023: $3,750 · 2024: $769 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,018 · Food and Beverage: $1,618 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,017.62 |
| Food and Beverage | $1,617.98 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13,092.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $12,089.11 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $9,208.00 | 2019-2022 | |
| Medtronic, INC. | $3,516.86 | 2021-2025 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $2,336.99 | 2019-2023 | |
| Medtronic Minimed, INC. | $1,151.49 | 2019-2020 | |
| Lilly USA, LLC | $407.47 | 2020-2024 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.03 | 2019-2025 | Synjardy, Jardiance, Tradjenta |
| Amgen INC. | $205.31 | 2019-2024 | Evenity, Prolia |
| Abbvie INC. | $116.09 | 2019-2023 | |
| Antares Pharma, INC. | $107.47 | 2019-2020 | |
| Horizon Therapeutics Plc | $102.86 | 2019-2020 | |
| Insulet Corporation | $100.06 | 2019-2022 | |
| Corcept Therapeutics | $75.26 | 2024 | Korlym |
| Amarin Pharma, INC. | $74.99 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $67.45 | 2019-2020 | |
| Sanofi Pasteur INC. | $63.83 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $46.15 | 2019-2020 | |
| Pfizer INC. | $40.57 | 2019-2024 | |
| Tandem Diabetes Care, INC. | $39.69 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Madrigal Pharmaceuticals | $36.27 | 2025 | Rezdiffra |
| Eisai INC. | $24.09 | 2019 | |
| Therapeuticsmd, INC. | $23.23 | 2019 | |
| Dexcom, INC. | $22.74 | 2023 | Dexcom G6 Transmitter |
| Vivus LLC | $22.61 | 2020 | |
| Sunovion Pharmaceuticals INC. | $22.09 | 2020 | |
| Senseonics, Incorporated | $22.00 | 2019 | |
| Abbott Laboratories | $20.60 | 2024 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $18.60 | 2020 | |
| Astellas Pharma US INC | $16.91 | 2019 | |
| Shire North American Group INC | $15.83 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.58 | 2024 | Unithroid |
| Companion Medical, INC. | $13.87 | 2019 | |
| Hikma Pharmaceuticals USA | $13.83 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.29 | 2019 | |
| Valeritas, INC. | $11.15 | 2019 | |
| Dynavax Technologies Corporation | $9.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Kaulbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.